Liposomal and Targeted Delivery: Technological Advancements Fueling the 4.81% CAGR in the Doxorubicin Market
Technological advancements in drug formulation and delivery mechanisms are playing a pivotal role in maintaining the growth momentum of the Doxorubicin Market, which is projected to expand at a 4.81% Compound Annual Growth Rate (CAGR). The conventional formulation of Doxorubicin, while highly effective, is constrained by the risk of severe side effects, most notably cumulative cardiotoxicity....
ไลค์
รัก
5
2 ความคิดเห็น 0 แชร์ 1764 ยอดวิว 0 รีวิว